2X-121 and dovitinib
AL-2003
Phase 1 small_molecule on_hold
Quick answer
2X-121 and dovitinib for Advanced Solid Tumors is a Phase 1 program (small_molecule) at Allarity Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Allarity Therapeutics
- Indication
- Advanced Solid Tumors
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- on_hold